
- BioPharm International-11-15-2017
- Volume 2017 eBook
- Issue 3
Accelerating Vaccine Development and Manufacturing
The use of approved platform technologies can reduce the time and cost required to generate new vaccines.
Established vaccine manufacturing technologies are complex, often highly customized, and typically require dedicated facilities. Development and approval times can be lengthy, presenting hurdles for medical professionals seeking rapid response to pandemic diseases.
Standardized vaccine manufacturing platforms that can be deployed across different vaccines and vaccine types, could speed the delivery of vaccines and enable manufacturing in emerging economies. Technical and funding challenges must be overcome to bring the advanced manufacturing potential to reality.
Download
eBook.
Article Details
Pharmaceutical Technology and BioPharm International
eBook: Vaccine Development and Manufacturing 2017
November 2017
Pages: 11–19
Citation
When referring to this article, please cite it as C Challener, " Accelerating Vaccine Development and Manufacturing," Pharmaceutical Technology and BioPharm International Vaccine Development and Manufacturing 2017 eBook (November 2017).
Articles in this issue
almost 8 years ago
Designing and Operating Flexible, High-Containment Vaccine Manufacturingalmost 8 years ago
Therapeutic Vaccines Target Cancer and Other Viral-Induced Diseasesalmost 8 years ago
Cold Chain: Delivering Vaccines to Patientsalmost 8 years ago
Using Human Challenge Trials to Develop Flu Vaccinesalmost 8 years ago
Moving to Closed Systems for Aseptic Processingalmost 8 years ago
Making Vaccines AccessibleNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.